Dilek DİLLİ, Ayşegül ZENCİROĞLU, Senem ÖZGÜR, Utku Arman ORUN, Seda AYDOĞAN, Hasan AKDUMAN, Başak KAYA GÜRSOY, Rümeysa ÇİTLİ, Nurdan DİNLEN FETTAH, Serpil KAYA ÇELEBİ

Neonatal Supraventriküler Taşikardi: Tek merkez Deneyiminin 10 Yıllık sonuçları

Amaç: Yenidoğanlarda en sık acil kardiyak müdahale gerektiren durumlardan biri olan supraventriküler taşikardi (SVT), aynı zamanda yenidoğanlarda en yaygın görülen semptomatik taşiaritmidir. Bu nedenle erken tanı ve tedavi yaklaşımı önemlidir. Yöntemler: Hastanemiz Yenidoğan Yoğun Bakım Ünitesinde Ocak 2011-Kasım 2020 tarihleri arasında SVT tanısı ile yatırılan yenidoğanların demografik ve klinik bulguları ile tedavi yaklaşımları retrospektif olarak değerlendirildi. Bulgular: Konjenital kalp hastalığı olmayan (sekundum tip atriyal septal defekt dışında) ve SVT tanısı alan 38 hasta retrospektif olarak değerlendirildi. Ortalama gebelik haftası 38.2 ± 1.8, ortalama tanı yaşı 10.7 ± 10.1 gün, kalp yetmezliği olan hasta sayısı 8 (%21), Wolff-Parkinson White sendromlu hasta sayısı 8 (%21), fetal aritmili hasta sayısı 6 (%15.7) ve ortalama yatış gün sayısı 15.7±13.5 idi. Hastalara medikal tedavi olarak birinci aşamada adenozin, ikinci aşamada propranolol, amiodaron, propafenon ve flekainid verildi. Dirençli SVT nedeniyle 5 (%13) hastaya kardiyoversiyon uygulandı. Sonuç: Supraventriküler taşikardinin erken tanı ve tedavisi, morbidite ve mortaliteyi azaltması açısından oldukça önemlidir. Bu nedenle yeni doğan bebekleri takip eden klinisyenler arasında SVT farkındalığının artmasının bu yenidoğanların erken tanı ve tedavi almalarını sağlayacağını düşünüyoruz.

Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution

Objective: Supraventricular tachycardia, one of the most common conditions requiring emergency cardiac intervention in newborns, is also the most common symptomatic tachyarrhythmia in newborns. Therefore, early diagnosis and treatment approach is important. Method: Demographic findings, clinical findings, and treatment approaches of newborns hospitalized with the diagnosis of supraventricular tachycardia between January 2011 and November 2020 in the Neonatal Intensive Care Unit of our hospital were evaluated retrospectively. Results: Thirty-eight patients without congenital heart disease (except secundum-type atrial septal defect) and diagnosed with supraventricular tachycardia were evaluated retrospectively. The mean week of gestation was 38.2 ± 1.8, the mean age at diagnosis was 10.7 ± 10.1 days, the number of patients with heart failure was 8 (21%), the number of patients with Wolff-Parkinson White syndrome was 8 (21%), the number of patients with fetal arrhythmia was 6 (15.7%) and the mean number of hospitalization days was 15.7±13.5. The patients were given adenosine in the first stage and propranolol, amiodarone, propafenone and flecainide in the second stage as medical treatment. Cardioversion was performed in 5 (13%) patients due to resistant supraventricular tachycardia. Conclusion: Early diagnosis and treatment of supraventricular tachycardia are very important in terms of reducing morbidity and mortality. Therefore, we think that increasing awareness of supraventricular tachycardia among clinicians following newborn babies will enable newborns with supraventricular tachycardia to receive early diagnosis and treatment.

PDF

___

1. Spearman AD, Williams P. Supraventricular tachycardia in infancy and childhood. Pediatric annals. 2014; 43: 456-60.
2. O'Connor BK, Dick M, 2nd. What every pediatrician should know about supraventricular tachycardia. Pediatric annals. 1991; 20: 368,71-6.
3. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27- year period at a single institution. Acta paediatrica. 2008; 97: 1035-39.
4. Srinivasan C, Balaji S. Neonatal supraventricular tachycardia. Indian Pacing Electrophysiol J. 2019; 19: 222-31.
5. Bilici M, Demir F. Pediatrik disritmiler. Dicle Tıp Dergisi. 2015; 42: 128-35.
6. Guerrier K, Shamszad P, Czosek RJ, et al. Variation in Antiarrhythmic Management of Infants Hospitalized with Supraventricular Tachycardia: A Multi-Institutional Analysis. Pediatr Cardiol. 2016; 37: 946-52.
7. Ban JE. Neonatal arrhythmias: diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017; 60: 344-52.
8. Malekian A, Khalilian MR, Dehdashtian M, Aramesh MR, Heydaripoor K. Evaluation and Management of Neonatal Supraventricular Tachycardia. J. Compr. Pediatr. 2016; 7: 3.
9. Stambach D, Bermet V, Bauersfeld U. Clinical recognition and treatment of atrial ectopic tachycardia in newborns. Swiss Mes Wkly. 2007; 137: 402-6.
10. Wu MH, Chen HC, Kao FY, Huang SK. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: A national birth cohort database study. Heart rhythm. 2016; 13: 2070-75.
11. Bjeloševič M, Illíková V, Tomko J, et al. Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10‐year population‐based study. Pacing Clin Electrophysiol. 2020; 43: 680-86.
12. Jr GA, A L. Supraventricular tachycardia. The Science and Practice of Pediatric Cardiology. 1990; 3: 1809-48.
13. Etheridge SP, Judd VE. Supraventricular tachycardia in infancy: evaluation, management, and follow-up. Archives of pediatrics & adolescent medicine. 1999; 153: 267-71.
14. Hrtankova M, Biringer K, Siváková J, et al. Fetal magnetocardiography: a promising way to diagnose fetal arrhytmia and to study fetal heart rate variability?. Ceska Gynekol. 2015; 80: 58-63.
15. Kothari D, Skinner J. Neonatal tachycardias: an update. Archives of disease in childhood Fetal and neonatal edition. 2006; 91: F136.
16. Oudijk MA, Visser GH, Meijboom EJ. Fetal tachyarrhythmia-Part I: diagnosis. Indian Pacing Electrophysiol. 2004; 4: 104.
17. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstetrics & Gynecology. 2000; 96: 575-81.
18. Naheed ZJ, Strasburger JF, Deal BJ, Woodrow Benson D, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol. 1996; 27: 1736-40.
19. Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011; 124: 1747-54.
20. Simpson J, Sharland G. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998; 79: 576-81.
21. Kundak AA, Dilli D, Karagöl B, et al. Non benign neonatal arrhythmias observed in a tertiary neonatal intensive care unit. Indian J Pediatr. 2013; 80: 555-59.
22. Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol. 2006; 27: 199-203.